<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"
                      "http://www.w3.org/TR/REC-html40/loose.dtd">
<html>
<head>
<title>extropians: TECH: Good articles on bioinformatics, future medic</title>
<meta name="Author" content="Max More (max@maxmore.com)">
<meta name="Subject" content="TECH: Good articles on bioinformatics, future medicine, speech interfaces">
</head>
<body bgcolor="#FFFFFF" text="#000000">
<h1>TECH: Good articles on bioinformatics, future medicine, speech interfaces</h1>
<!-- received="Fri Oct 26 00:11:39 2001" -->
<!-- isoreceived="20011026061139" -->
<!-- sent="Thu, 25 Oct 2001 23:13:46 -0700" -->
<!-- isosent="20011026061346" -->
<!-- name="Max More" -->
<!-- email="max@maxmore.com" -->
<!-- subject="TECH: Good articles on bioinformatics, future medicine, speech interfaces" -->
<!-- id="5.1.0.14.2.20011025231202.051c1090@mail.speakeasy.net" -->
<strong>From:</strong> Max More (<a href="mailto:max@maxmore.com?Subject=Re:%20TECH:%20Good%20articles%20on%20bioinformatics,%20future%20medicine,%20speech%20interfaces&In-Reply-To=&lt;5.1.0.14.2.20011025231202.051c1090@mail.speakeasy.net&gt;"><em>max@maxmore.com</em></a>)<br>
<strong>Date:</strong> Fri Oct 26 2001 - 00:13:46 MDT
<p>
<!-- next="start" -->
<ul>
<li><strong>Next message:</strong> <a href="1738.html">Samantha Atkins: "Re:"</a>
<li><strong>Previous message:</strong> <a href="1736.html">Brian Atkins: "Re: Oil Pipeline ( was  Tolerance strategies)"</a>
<!-- nextthread="start" -->
<li><strong>Next in thread:</strong> <a href="1754.html">J. R. Molloy: "Re: Good articles on bioinformatics, future medicine, speech  interfaces"</a>
<li><strong>Reply:</strong> <a href="1754.html">J. R. Molloy: "Re: Good articles on bioinformatics, future medicine, speech  interfaces"</a>
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#1737">[ date ]</a>
<a href="index.html#1737">[ thread ]</a>
<a href="subject.html#1737">[ subject ]</a>
<a href="author.html#1737">[ author ]</a>
</ul>
<hr noshade><p>
<!-- body="start" -->
<p>
Some interesting pieces:
<br>
<p><p>Look Who's Talking
<br>
After a decade of deafness, speech interfaces finally are ready to listen
<br>
<a href="http://www.cio.com/archive/101501/et_revisit.html">http://www.cio.com/archive/101501/et_revisit.html</a>
<br>
Fred Hapgood
<br>
CIO.com, October 15, 2001
<br>
<p><p>Scenarios: Regenerative Medicine is the Future
<br>
By Peter Schwartz
<br>
Red Herring, October 17, 2001
<br>
<a href="http://www.redherring.com/index.asp?layout=story&channel=10000001&doc_id=1600020360&rh_special_report_id">http://www.redherring.com/index.asp?layout=story&channel=10000001&doc_id=1600020360&rh_special_report_id</a>=
<br>
<p><p>Brain Researchers Ponder Mechanical Minds
<br>
By Thomas Maeder
<br>
Red Herring, October 18, 2001
<br>
<a href="http://www.redherring.com/index.asp?layout=story&channel=10000001&doc_id=1730020373&rh_special_report_id">http://www.redherring.com/index.asp?layout=story&channel=10000001&doc_id=1730020373&rh_special_report_id</a>=
<br>
<p><p>Drug Companies on Speed
<br>
BIOINFORMATICS
<br>
CIO.com, October 15, 2001
<br>
The marriage of IT and medical research may be just what traditional 
<br>
pharmaceutical companies need to survive in an increasingly competitive 
<br>
field. BY STEPHANIE OVERBY
<br>
<a href="http://www.cio.com/archive/101501/speed.html">http://www.cio.com/archive/101501/speed.html</a>
<br>
Nearly 75 percent of the drug candidates currently being tested by 
<br>
pharmaceutical companies will fall short of expectations and never reach 
<br>
market, resulting in an average of $880 million and 15 years to develop 
<br>
each new medicine that does make it. Some analysts predict that 
<br>
bioinformatics could help cut in half the cost of creating a drug and shave 
<br>
two to three years off its development. This new category of IT tool uses 
<br>
computers to store, organize, generate, retrieve, analyze and share 
<br>
genomic, biological and chemical data. Merck researchers used 
<br>
bioinformatics to compare the entire genome sequence for mice and humans 
<br>
and discovered a gene in mice that might have the same function as a human 
<br>
gene affecting schizophrenia.
<br>
<p>Hundreds of vendors are jumping on the bioinformatics bandwagon and there 
<br>
are very few standards.The challenge for CIOs is to piece together these 
<br>
diverse technologies into a fully integrated drug discovery process.
<br>
_____________________
<br>
<p>Onward!
<br>
<p>Max
<br>
<p><p>_______________________________________________________
<br>
Max More, Ph.D.
<br>
<a href="mailto:max@maxmore.com?Subject=Re:%20TECH:%20Good%20articles%20on%20bioinformatics,%20future%20medicine,%20speech%20interfaces&In-Reply-To=&lt;5.1.0.14.2.20011025231202.051c1090@mail.speakeasy.net&gt;">max@maxmore.com</a> or <a href="mailto:more@extropy.org?Subject=Re:%20TECH:%20Good%20articles%20on%20bioinformatics,%20future%20medicine,%20speech%20interfaces&In-Reply-To=&lt;5.1.0.14.2.20011025231202.051c1090@mail.speakeasy.net&gt;">more@extropy.org</a>
<br>
<a href="http://www.maxmore.com">http://www.maxmore.com</a>
<br>
Strategic Philosopher
<br>
President, Extropy Institute. <a href="http://www.extropy.org">http://www.extropy.org</a> &lt;<a href="mailto:more@extropy.org?Subject=Re:%20TECH:%20Good%20articles%20on%20bioinformatics,%20future%20medicine,%20speech%20interfaces&In-Reply-To=&lt;5.1.0.14.2.20011025231202.051c1090@mail.speakeasy.net&gt;">more@extropy.org</a>&gt;
<br>
________________________________________________________________
<br>
Senior Content Architect, ManyWorlds Inc.: <a href="http://www.manyworlds.com">http://www.manyworlds.com</a>
<br>
--- Thought leadership in the innovation economy
<br>
<a href="mailto:m.more@manyworlds.com?Subject=Re:%20TECH:%20Good%20articles%20on%20bioinformatics,%20future%20medicine,%20speech%20interfaces&In-Reply-To=&lt;5.1.0.14.2.20011025231202.051c1090@mail.speakeasy.net&gt;">m.more@manyworlds.com</a>
<br>
_______________________________________________________
<br>
<p><!-- body="end" -->
<hr noshade>
<ul>
<!-- next="start" -->
<li><strong>Next message:</strong> <a href="1738.html">Samantha Atkins: "Re:"</a>
<li><strong>Previous message:</strong> <a href="1736.html">Brian Atkins: "Re: Oil Pipeline ( was  Tolerance strategies)"</a>
<!-- nextthread="start" -->
<li><strong>Next in thread:</strong> <a href="1754.html">J. R. Molloy: "Re: Good articles on bioinformatics, future medicine, speech  interfaces"</a>
<li><strong>Reply:</strong> <a href="1754.html">J. R. Molloy: "Re: Good articles on bioinformatics, future medicine, speech  interfaces"</a>
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#1737">[ date ]</a>
<a href="index.html#1737">[ thread ]</a>
<a href="subject.html#1737">[ subject ]</a>
<a href="author.html#1737">[ author ]</a>
</ul>
<!-- trailer="footer" -->
<hr noshade>
<p>
<small>
<em>
This archive was generated by <a href="http://www.hypermail.org/">hypermail 2b30</a> 
: <em>Sat May 11 2002 - 17:44:16 MDT</em>
</em>
</small>
</body>
</html>
